RT @SCCR_Stanford: In a pooled cohort of 4 #RCTs, authors (including #SCCR's Ken Mahaffey) showed that post-discharge #bleeding is associat…
An updated, pragmatic, evidence-based consensus statement published in @JACCJournals will hopefully help clinicians managing bleeding in patients on blood thinners. https://t.co/LiBM5BY6XB
A recently published consensus statement in @JACCJournals talks about managing bleeding in DOAC patients. #SCCR director Ken Mahaffey (@TheMahaf) is an author. https://t.co/LiBM5BY6XB
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
Sangrado postegreso luego sindrome coronario agudo asoc c/aumento similar en mortalidad posterior por todas las causas en pac tratados con intervención coronaria percutánea o no y tendría un pronóstico equivalente que el infarto miocárdico postegreso https
RT @GBarnesMD: The time-course associated with drug-related bleeding is critical. Bleeding (and adverse events) closely associate with star…
RT @G_MarquisGravel: In this pooled cohort of 4 #RCTs, we showed that post-discharge #bleeding is associated with mortality after #ACS, reg…
RT @RenatoDLopes1: Important work by Guillaume. Congrats.
RT @G_MarquisGravel: In this pooled cohort of 4 #RCTs, we showed that post-discharge #bleeding is associated with mortality after #ACS, reg…
RT @G_MarquisGravel: In this pooled cohort of 4 #RCTs, we showed that post-discharge #bleeding is associated with mortality after #ACS, reg…
RT @GBarnesMD: The time-course associated with drug-related bleeding is critical. Bleeding (and adverse events) closely associate with star…
The time-course associated with drug-related bleeding is critical. Bleeding (and adverse events) closely associate with starting #cvCoag and anti-platelet medications. Risk mitigates over time, as if passing a “bleeding stress test”
Important work by Guillaume. Congrats.
In this pooled cohort of 4 #RCTs, we showed that post-discharge #bleeding is associated with mortality after #ACS, regardless of index treatment strategy (medical or #PCI) @JACCJournals https://t.co/8AwUNtpPZ4 @MTRHeart @RenatoDLopes1 @HeartBobH @TheMah
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
RT @F_dalgaard: Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated…
Read our pooled analysis from 4 trials: How does bleeding after discharge for ACS affect mortality in ACS patients treated with either PCI or no PCI? Answer: Bleeding imposes a high risk of mortality regardless of PCI. Out now in @JACCJournals with @G_Marq
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
Great work from @G_MarquisGravel !!
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
RT @JACCJournals: The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated witho…
The long-term prognostic impact of post-discharge bleeding in the unique population of patients with #cvACS treated without #PCI remains unexplored. New #JACC analysis examines outcomes in these patients: https://t.co/bkhGhipBhv https://t.co/39KOu6zjQn
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI | JACC: Journal of the American College of Cardiology https://t.co/fdxBmbyZy6
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
Muy importante para todos nuestros pacientes con síndromes coronarios agudos
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
RT @gonzaeperez: SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d…
SANGRADO AL ALTA EN PAC CON SCA CON O SIN #PCI >45000 Pac ⏩APRAISE2 PLATO TRACER y TRILOGY ACS. Sangrado⬆️riesgo💀a 30 d y a 12 m. en los Pac con o sin #PCI @JACCJournals @gabrielsteg @RenatoDLopes1 https://t.co/lkJh0jtIFG https://t.co/Z6Pay0pnzH